Patient Lifestyle

The company received approval for solifenacin succinate tablets, ranolazine extended-release tablets and sildenafil for oral suspension.

For the first quarter, sales decreased 1.5% year-over-year to $33.4 billion, while adjusted EPS decreased 30.8% to $1.16, down 29.9% on a constant currency basis. 

Gail Lebovic’s recent move in health care came in 2020, with the formation of Silicon Valley Innovations, and its OTC flagship product, NasoClenz.

The United States Court of Appeals for the Federal Circuit has granted a motion to temporarily enjoin the generic launch by Teva and Apotex of Hetlioz.

The second panel at Drug Store News’ 24th annual Industry Issues Summit explored how retailers and pharmacy technology companies are responding to customers’ and patients’ needs.

The new collaboration leverages MyEyeDr.’s 850+ offices to refer patients into ophthalmology clinical trials.

Hemgenix is the first gene therapy to treat adults with Hemophilia B.

Sezaby is the first and only product approved for treating seizures in neonatal patients.